Submitted on May 9, 2013
Topic Area(s):
Image
Prostate cancer ranks as the most common internal malignancy diagnosed in men in the United States, but often does not require extensive treatment..
A study using tissue samples from men who underwent surgical removal of the prostate at UC San Francisco confirmed that a genetic test that measures cell cycle progression (CCP) — an indicator of how rapidly cancer cells are growing and dividing — can be a useful tool for predicting who will have a recurrence of the disease, especially when combined with existing information from laboratory and pathology tests.
Click here to read full story from UCSF